Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析

◆英語タイトル:Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31788FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nippon Shinyaku Co Ltd (4516) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nippon Shinyaku Co Ltd (Nippon Shinyaku) develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; gastrointestinal disorders; cardiovascular and metabolic diseases among others. Nippon Shinyaku also provides functional food ingredients including health food ingredients, preservatives, spices and condiments, and protein preparations. Its functional food products find application in meat processing, fish processing, dairy product, prepared food, confectionery and bakery, and beverage, among others. The company operates business through a network of offices and research laboratories in Japan, China, the UK and the US. Nippon Shinyaku is headquartered in Minami-ku, Kyoto, Japan.

Nippon Shinyaku Co Ltd Key Recent Developments

Nov 13,2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01,2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24,2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20,2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nippon Shinyaku Co Ltd – Key Facts
Nippon Shinyaku Co Ltd – Key Employees
Nippon Shinyaku Co Ltd – Key Operational Employees
Nippon Shinyaku Co Ltd – Major Products and Services
Nippon Shinyaku Co Ltd – History
Nippon Shinyaku Co Ltd – Company Statement
Nippon Shinyaku Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nippon Shinyaku Co Ltd – Business Description
Business Segment: Functional Food
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Nippon Shinyaku Co Ltd – Corporate Strategy
Nippon Shinyaku Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nippon Shinyaku Co Ltd – Strengths
Nippon Shinyaku Co Ltd – Weaknesses
Nippon Shinyaku Co Ltd – Opportunities
Nippon Shinyaku Co Ltd – Threats
Nippon Shinyaku Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2020: The “Moshikashite NMD” project is launched. Special dance and check tools are developed collaboratively to help discover neuromuscular disorders earlier
Jul 01, 2020: Nippon Shinyaku : Investment in the newly established Biotech funds
Mar 24, 2020: Nippon Shinyaku announces final completion of API manufacturing building
Jan 20, 2020: Nippon Shinyaku signed the United Nations Global Compact (UNGC)
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nippon Shinyaku Co Ltd, Key Facts
Nippon Shinyaku Co Ltd, Key Employees
Nippon Shinyaku Co Ltd, Key Operational Employees
Nippon Shinyaku Co Ltd, Major Products and Services
Nippon Shinyaku Co Ltd, History
Nippon Shinyaku Co Ltd, Other Locations
Nippon Shinyaku Co Ltd, Subsidiaries
Nippon Shinyaku Co Ltd, Key Competitors
Nippon Shinyaku Co Ltd, Ratios based on current share price
Nippon Shinyaku Co Ltd, Annual Ratios
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...1)
Nippon Shinyaku Co Ltd, Annual Ratios (Cont...2)
Nippon Shinyaku Co Ltd, Interim Ratios
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Nippon Shinyaku Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bailian Group Co., Ltd.:企業の戦略的SWOT分析
    Bailian Group Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Celsense Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • Mission Pharmacal Company:製薬・医療:M&Aディール及び事業提携情報
    Summary Mission Pharmacal Company (Mission Pharmacal) develops, manufactures and markets prescription, over-the-counter and dietary supplement products. It offers products for conditions related to women’s health, urology, pediatrics, and dermatology, among others. It also offers contract manufactur …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Meridian Bioscience Inc (VIVO):医療機器:M&Aディール及び事業提携情報
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, an …
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Rosenergoatom Concern:企業の戦略的SWOT分析
    Rosenergoatom Concern - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ValiRx Plc (VAL):医療機器:M&Aディール及び事業提携情報
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Calumet Specialty Products Partners, L.P.:企業のM&A・事業提携・投資動向
    Calumet Specialty Products Partners, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Calumet Specialty Products Partners, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Planung Transport Verkehr AG:企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nippon Seiro Co., Ltd. (5010):企業の財務・戦略的SWOT分析
    Nippon Seiro Co., Ltd. (5010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) operates as a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, electronic laparoscope devices, neurova …
  • Holtec International Inc:企業の戦略的SWOT分析
    Holtec International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • PACCAR Inc.:企業の戦略・SWOT・財務情報
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務情報
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Msig Holdings (Asia) Pte. Ltd.
    Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen), formerly Svenska Capital Oil AB is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It offers de …
  • Reliance Infrastructure Ltd.:企業の戦略・SWOT・財務情報
    Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆